Literature DB >> 10851807

Microwave thermochemotherapy in the treatment of the bladder carcinoma--electromagnetic and dielectric studies--clinical protocol.

A Dietsch1, J C Camart, J P Sozanski, B Prevost, B Mauroy, M Chivé.   

Abstract

Microwave thermotherapy is currently used in clinical routines for benign prostatic hyperplasia treatments. The temperature increase is obtained using an endocavitary microwave applicator placed in the prostatic urethra. This urethral applicator after a technical modification can be placed inside the bladder in order to potentiate the effects of the treatment by chemotherapy of vesical carcinoma. This paper deals with electromagnetic studies of this new endocavitary applicator. First of all, the experimental determination of the dielectric permittivities for the propagation domain characterization is achieved in order to be used in the electromagnetic model. Compared to experimental results, these simulations obtained by the finite-difference time-domain formalism allow us to determine the electromagnetic performance of this applicator. Finally, the in vivo study realized on anesthetized dogs to determine the therapeutic protocol associating chemotherapy and thermotherapy in the treatment of the bladder cancer is presented.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10851807     DOI: 10.1109/10.841335

Source DB:  PubMed          Journal:  IEEE Trans Biomed Eng        ISSN: 0018-9294            Impact factor:   4.538


  2 in total

1.  Modeling the detectability of vesicoureteral reflux using microwave radiometry.

Authors:  Kavitha Arunachalam; Paolo F Maccarini; Valeria De Luca; Fernando Bardati; Brent W Snow; Paul R Stauffer
Journal:  Phys Med Biol       Date:  2010-08-25       Impact factor: 3.609

2.  Detection of vesicoureteral reflux using microwave radiometry-system characterization with tissue phantoms.

Authors:  Kavitha Arunachalam; Paolo Maccarini; Valeria De Luca; Piero Tognolatti; Fernando Bardati; Brent Snow; Paul Stauffer
Journal:  IEEE Trans Biomed Eng       Date:  2011-01-20       Impact factor: 4.538

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.